Jump to content
RemedySpot.com

D2E7

Rate this topic


Guest guest

Recommended Posts

Carol, I haven't heard anything about the price of D2E7. Usually the

manufacturer keeps that information very quiet until it looks quite

certain that the product will actually be sold and the moment to release

the news is just right. Such a big game!

I would guess that, unfortunately, it will be very expensive. It's not

an easy product to make and they will be going head to head with

Remicade (infliximab) and Enbrel (etanercept). It's hard to imagine that

it will be a bargain.

[ ] D2E7

> or a,

>

> Have you heard what this drug is going to cost when it is brought to

market

> next year?

>

> Just curious.

>

> Love and hugs,

> Carol

Link to comment
Share on other sites

Hi ,

Since I wrote that, I found one business source that estimated the price to

consumers to be about $600 per month, or 40% less than Enbrel. Hopefully

that will be the case. It's still expensive, but it's a step in the right

direction.

Love,

Carol

Re: [ ] D2E7

Carol, I haven't heard anything about the price of D2E7. Usually the

manufacturer keeps that information very quiet until it looks quite

certain that the product will actually be sold and the moment to release

the news is just right. Such a big game!

I would guess that, unfortunately, it will be very expensive. It's not

an easy product to make and they will be going head to head with

Remicade (infliximab) and Enbrel (etanercept). It's hard to imagine that

it will be a bargain.

[ ] D2E7

> or a,

>

> Have you heard what this drug is going to cost when it is brought to

market

> next year?

>

> Just curious.

>

> Love and hugs,

> Carol

Link to comment
Share on other sites

Carol, I saw that same figure at one site, but it didn't look as if the

document were for public consumption. It would be nice if there were a

less costly but equally effective anti-TNF product out there. Time will

tell. Interesting, too, that there are no trials comparing D2E7

(adalimumab) directly to either of the other TNF inhibitors.

If Immunex/Amgen/Wyeth group doesn't get its act together and get the

Enbrel supply going strong, Abbott may be able to charge more than that.

I hope not though! Even $300 per dose is a budget-buster.

Re: [ ] D2E7

>

> Carol, I haven't heard anything about the price of D2E7. Usually the

> manufacturer keeps that information very quiet until it looks quite

> certain that the product will actually be sold and the moment to

release

> the news is just right. Such a big game!

>

> I would guess that, unfortunately, it will be very expensive. It's not

> an easy product to make and they will be going head to head with

> Remicade (infliximab) and Enbrel (etanercept). It's hard to imagine

that

> it will be a bargain.

>

>

Link to comment
Share on other sites

It's amazing that I'm to the point I consider a $600 per month price tag a

bargain!

Love and hugs,

Carol

Re: [ ] D2E7

Carol, I saw that same figure at one site, but it didn't look as if the

document were for public consumption. It would be nice if there were a

less costly but equally effective anti-TNF product out there. Time will

tell. Interesting, too, that there are no trials comparing D2E7

(adalimumab) directly to either of the other TNF inhibitors.

If Immunex/Amgen/Wyeth group doesn't get its act together and get the

Enbrel supply going strong, Abbott may be able to charge more than that.

I hope not though! Even $300 per dose is a budget-buster.

Re: [ ] D2E7

>

> Carol, I haven't heard anything about the price of D2E7. Usually the

> manufacturer keeps that information very quiet until it looks quite

> certain that the product will actually be sold and the moment to

release

> the news is just right. Such a big game!

>

> I would guess that, unfortunately, it will be very expensive. It's not

> an easy product to make and they will be going head to head with

> Remicade (infliximab) and Enbrel (etanercept). It's hard to imagine

that

> it will be a bargain.

>

>

Link to comment
Share on other sites

Oh great, getting herpes as a side effect? Gheeeeeeeeeeeesh...

Is it just me, or are some of these biologics just not " quite ready for

prime time " ?

Suzanne

[ ] D2E7 - Stacey

> Stacey, the side-effect profile of D2E7 will probably be similar to those

of

> Enbrel and Remicade since all three are TNF-alpha inhibitors. They are

expecting

> fewer side-effects with D2E7 (adalimumab) than Remicade since it is " fully

human "

> (no mouse parts). We'll see.

>

> Check this out:

>

> " The most frequent side effects were injection site reactions, which

> were three- to five-fold more common with adalimumab, at 15 percent,

> compared to 3 percent for placebo. Infection complications were similar

> in both groups except for a two- to three-fold increase in herpes

> simplex. Three patients on placebo and six on adalimumab withdrew from

> the treatment. "

>

> http://www.docguide.com/dg.nsf/PrintPrint/E5C244FDA6FD0F0E85256A6C0052E3C3

>

>

Link to comment
Share on other sites

Suzanne, it's not that the biologics " give " you herpes simplex, it's

that certain medications such as these interfere with your immune

system in such a way that you are more susceptible to a new infection or

reactivation of a latent virus or bacterium you have already previously

acquired. Herpes simplex includes both HSV-1 and HSV-2; HSV-1 is the one

responsible for cold sores, and HSV-2 causes genital herpes. Both are

contracted from contact with an infected person, but HSV-2 only through

sexual contact.

http://www.aad.org/pamphlets/herpes.html

I do agree that there is still much to be learned about how exactly

these drugs will affect us, especially long-term, but it is important to

keep in mind that even old standbys like MTX and prednisone also

increase the chance for opportunistic infections or recurrence of latent

ones.

[ ] D2E7 - Stacey

>

>

> > Stacey, the side-effect profile of D2E7 will probably be similar to

those

> of

> > Enbrel and Remicade since all three are TNF-alpha inhibitors. They

are

> expecting

> > fewer side-effects with D2E7 (adalimumab) than Remicade since it is

" fully

> human "

> > (no mouse parts). We'll see.

> >

> > Check this out:

> >

> > " The most frequent side effects were injection site reactions, which

> > were three- to five-fold more common with adalimumab, at 15 percent,

> > compared to 3 percent for placebo. Infection complications were

similar

> > in both groups except for a two- to three-fold increase in herpes

> > simplex. Three patients on placebo and six on adalimumab withdrew

from

> > the treatment. "

> >

> >

http://www.docguide.com/dg.nsf/PrintPrint/E5C244FDA6FD0F0E85256A6C0052E3

C3

> >

> >

Link to comment
Share on other sites

Many years ago I managed to acquire warts in my genital area from taking

birth control pills.....My soon to be husband managed to get one too...so we

had to abstain, I couldn't take the pill any more, and I had to go about

getting mine removed by burning them off by freezing them(ouch!!!!)and then

his went away ....the Gyn said we were lucky to not have managed to get them

on the inside of me as that was a much harder thing to deal with....but it is

amazing some of the ways our bodies react to certain things.....it is now

manyyrs later (30!) and I take HRT(which is essentially BC pills again) and

no big deal now.Judy in AZ

Link to comment
Share on other sites

, aaahhhh, thanks. Still, it is interesting that the biologics

" activate " certain infections or bacteriums that would be best left

" unactiviated " .

Suzanne

Re: [ ] D2E7

> Suzanne, it's not that the biologics " give " you herpes simplex, it's

> that certain medications such as these interfere with your immune

> system in such a way that you are more susceptible to a new infection or

> reactivation of a latent virus or bacterium you have already previously

> acquired. Herpes simplex includes both HSV-1 and HSV-2; HSV-1 is the one

> responsible for cold sores, and HSV-2 causes genital herpes. Both are

> contracted from contact with an infected person, but HSV-2 only through

> sexual contact.

>

> http://www.aad.org/pamphlets/herpes.html

>

> I do agree that there is still much to be learned about how exactly

> these drugs will affect us, especially long-term, but it is important to

> keep in mind that even old standbys like MTX and prednisone also

> increase the chance for opportunistic infections or recurrence of latent

> ones.

>

>

Link to comment
Share on other sites

In my eyes, the biologicals are not only ready for prime time, they should

have an award. Enbrel is the first drug to really give me any relief. I¹m

in my 4th year on it and so far so good. But of course 4 years isn¹t

considered long term.

All meds have their problems. It¹s up to us to weigh the pros and cons and

decide if we can live with the cons.

a

> Suzanne, it's not that the biologics " give " you herpes simplex, it's

> that certain medications such as these interfere with your immune

> system in such a way that you are more susceptible to a new infection or

> reactivation of a latent virus or bacterium you have already previously

> acquired. Herpes simplex includes both HSV-1 and HSV-2; HSV-1 is the one

> responsible for cold sores, and HSV-2 causes genital herpes. Both are

> contracted from contact with an infected person, but HSV-2 only through

> sexual contact.

>

> http://www.aad.org/pamphlets/herpes.html

>

> I do agree that there is still much to be learned about how exactly

> these drugs will affect us, especially long-term, but it is important to

> keep in mind that even old standbys like MTX and prednisone also

> increase the chance for opportunistic infections or recurrence of latent

> ones.

>

>

>

>

> [ ] D2E7 - Stacey

>> >

>> >

>>> > > Stacey, the side-effect profile of D2E7 will probably be similar to

> those

>> > of

>>> > > Enbrel and Remicade since all three are TNF-alpha inhibitors. They

> are

>> > expecting

>>> > > fewer side-effects with D2E7 (adalimumab) than Remicade since it is

> " fully

>> > human "

>>> > > (no mouse parts). We'll see.

>>> > >

>>> > > Check this out:

>>> > >

>>> > > " The most frequent side effects were injection site reactions, which

>>> > > were three- to five-fold more common with adalimumab, at 15 percent,

>>> > > compared to 3 percent for placebo. Infection complications were

> similar

>>> > > in both groups except for a two- to three-fold increase in herpes

>>> > > simplex. Three patients on placebo and six on adalimumab withdrew

> from

>>> > > the treatment. "

>>> > >

>>> > >

> http://www.docguide.com/dg.nsf/PrintPrint/E5C244FDA6FD0F0E85256A6C0052E3

> C3

>>> > >

>>> > >

>

>

Link to comment
Share on other sites

a,

You've been on Embrel for 4 years? That's a long time. Wonderful that you

are having continue long term success with it. I guess it is all in the eye

of the beholder. I was terrified to take mtx. The reality has been okay.

Probably no different with the biologics. The fear of the unknown vs the

reality. You're right, any opportunity for relief is worth the attempt.

Still, the side affects sound alarming, I know, I know, just read the sides

for mtx. It's a crummy disease and the treatments seem scary too.

Suzanne

[ ] D2E7 - Stacey

>> >

>> >

>>> > > Stacey, the side-effect profile of D2E7 will probably be similar to

> those

>> > of

>>> > > Enbrel and Remicade since all three are TNF-alpha inhibitors. They

> are

>> > expecting

>>> > > fewer side-effects with D2E7 (adalimumab) than Remicade since it is

> " fully

>> > human "

>>> > > (no mouse parts). We'll see.

>>> > >

>>> > > Check this out:

>>> > >

>>> > > " The most frequent side effects were injection site reactions, which

>>> > > were three- to five-fold more common with adalimumab, at 15 percent,

>>> > > compared to 3 percent for placebo. Infection complications were

> similar

>>> > > in both groups except for a two- to three-fold increase in herpes

>>> > > simplex. Three patients on placebo and six on adalimumab withdrew

> from

>>> > > the treatment. "

>>> > >

>>> > >

> http://www.docguide.com/dg.nsf/PrintPrint/E5C244FDA6FD0F0E85256A6C0052E3

> C3

>>> > >

>>> > >

>

>

Link to comment
Share on other sites

Suzanne,

Enbrel was approved in September of 1998 and I started very soon after it

was approved. I had immediate results. There have been times over the

years that I swore I was injecting water, but all in all it has been the

first drug that has really helped me since being diagnosed over 25 years

ago. Sometimes I think I can see my joints deflating.

I was also terrified to take mtx especially after reading so many stories

about liver toxicity and lung complications. But like most meds, serious

side effects are rare. Because drug manufacturers are required to list all

known side effects, sometimes that list is pretty long and scary. It goes

to show you that these meds affect everyone differently and that is one

reason that the list is so long. Some people read that list and expect to

experience all the side effects. If I didn¹t already have such severe

damage to my joints, I probably wouldn¹t be so eager to try new meds.

Yeah, it¹s a crummy disease alright.

a

> a,

>

> You've been on Embrel for 4 years? That's a long time. Wonderful that you

> are having continue long term success with it. I guess it is all in the eye

> of the beholder. I was terrified to take mtx. The reality has been okay.

> Probably no different with the biologics. The fear of the unknown vs the

> reality. You're right, any opportunity for relief is worth the attempt.

> Still, the side affects sound alarming, I know, I know, just read the sides

> for mtx. It's a crummy disease and the treatments seem scary too.

>

> Suzanne

>

> [ ] D2E7 - Stacey

>>>> >> >

>>>> >> >

>>>>>> >>> > > Stacey, the side-effect profile of D2E7 will probably be similar

to

>> > those

>>>> >> > of

>>>>>> >>> > > Enbrel and Remicade since all three are TNF-alpha inhibitors.

They

>> > are

>>>> >> > expecting

>>>>>> >>> > > fewer side-effects with D2E7 (adalimumab) than Remicade since it

is

>> > " fully

>>>> >> > human "

>>>>>> >>> > > (no mouse parts). We'll see.

>>>>>> >>> > >

>>>>>> >>> > > Check this out:

>>>>>> >>> > >

>>>>>> >>> > > " The most frequent side effects were injection site reactions,

which

>>>>>> >>> > > were three- to five-fold more common with adalimumab, at 15

>>>>>> percent,

>>>>>> >>> > > compared to 3 percent for placebo. Infection complications were

>> > similar

>>>>>> >>> > > in both groups except for a two- to three-fold increase in herpes

>>>>>> >>> > > simplex. Three patients on placebo and six on adalimumab withdrew

>> > from

>>>>>> >>> > > the treatment. "

>>>>>> >>> > >

>>>>>> >>> > >

>> > http://www.docguide.com/dg.nsf/PrintPrint/E5C244FDA6FD0F0E85256A6C0052E3

>> > C3

>>>>>> >>> > >

>>>>>> >>> > >

>> >

>> >

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...